BPC‑157 10mg

BPC-157 10 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation. For research use only — not for human or veterinary use.  

Product Overview

BPC-157 is a synthetic peptide research compound widely investigated in experimental models involving peptide signalling, cellular response mechanisms and molecular communication pathways. Its defined peptide structure and established use in experimental peptide research have made BPC-157 a frequently investigated compound within modern biochemical and molecular laboratory studies. This preparation is supplied as a 10 mg labelled lyophilized BPC-157 research vial. Independent third-party analysis of this production batch measured an assay content of 14.21 mg with a reported analytical uncertainty of ±0.07 mg. Chromatographic analysis confirmed a purity of 99.5 percent, while peptide identity was independently evaluated through FTIR spectrum analysis, retention time analysis and mass spectrometry. Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count. Bacterial endotoxin analysis returned a result of 0.086 EU/mg, within the laboratory’s stated acceptable range of 0–0.5 EU/mg. Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. These independently generated analytical results provide researchers with detailed batch-specific documentation of identity, assay content, purity, microbiological quality and elemental impurity screening.  

Peptide Overview

BPC-157 is a synthetic peptide research compound commonly utilised in laboratory investigations involving peptide chemistry, molecular interactions and cellular signalling systems. Researchers employ BPC-157 in controlled experimental models designed to investigate peptide-mediated biochemical processes and interactions between peptide structures and biological research systems. Its defined molecular characteristics allow analytical techniques such as chromatographic purity assessment, retention time comparison, FTIR spectrum analysis and mass spectrometry to be used for batch-specific characterisation. These analytical characteristics make BPC-157 suitable as a well-defined research material for controlled peptide and biochemical laboratory investigations.  

Historical Background and Scientific Context

Advances in peptide synthesis and analytical chemistry have enabled researchers to produce and characterise increasingly well-defined synthetic peptide compounds for controlled laboratory investigation. Modern analytical technologies allow research peptides to be evaluated using multiple complementary techniques rather than relying on a single analytical measurement. Chromatographic analysis can assess assay content and purity, while FTIR spectrum comparison, retention time analysis and mass spectrometry provide additional information regarding molecular identity. Microbiological analysis, bacterial endotoxin testing and elemental impurity screening further contribute to the analytical characterisation of research-grade peptide preparations. BPC-157 continues to form part of this expanding field of experimental peptide science and controlled molecular research.  

Mechanistic Focus in Research

Within controlled laboratory environments, BPC-157 is investigated in relation to peptide-mediated signalling and biochemical interaction pathways. Research investigations may explore:

• Peptide-mediated cellular signalling
• Cellular response mechanisms
• Molecular communication pathways
• Peptide interaction studies
• Biochemical pathway analysis
• Comparative peptide investigations
• Controlled in vitro research models

These experimental models allow researchers to investigate peptide-related molecular mechanisms under carefully controlled laboratory conditions.  

Analytical Verification (COA)

Each Grail Formula production batch is supported by independent analytical documentation designed to provide transparent batch-specific information regarding the research material supplied. Analytical testing for this BPC-157 production batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectroscopic, microbiological and mass spectrometric analytical techniques. Batch: GF-BPC10-B242

• Labelled Product: BPC-157 10 mg
• Assay Content: 14.21 mg
• Purity: 99.5 %
• Identification by FTIR Spectrum: 995
• Identification by Retention Time: 0.998
• Molecular Ion Mass Identification: 1418 Da
• Bacterial Endotoxins: 0.086 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent peptide screening measured an assay content of 14.21 mg with an analytical uncertainty of ±0.07 mg. Purity analysis returned a result of 99.5 percent with a reported analytical uncertainty of ±0.5 percent. Identity evaluation included FTIR spectrum analysis with a reported result of 995 and retention time analysis with a result of 0.998. Mass spectrometry analysis identified a molecular ion mass of 1418 Da with a reported uncertainty of ±1 Da, providing an additional independent identity parameter for the tested material. Bacterial endotoxin analysis returned 0.086 EU/mg with a reported uncertainty of ±0.002 EU/mg, remaining within the laboratory’s stated acceptable range of 0–0.5 EU/mg. Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count. Elemental impurity screening reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. Together, these analytical procedures provide extensive independent batch-specific characterisation of BPC-157 identity, assay content, purity and laboratory quality parameters.  

Research Applications

Within controlled laboratory environments, BPC-157 may be utilised in experimental models designed to investigate peptide biology, molecular signalling and biochemical interaction pathways. Examples of research applications include:

• Peptide signalling investigations
• Cellular response research
• Molecular interaction studies
• Biochemical pathway analysis
• Comparative peptide investigations
• Peptide chemistry research
• Controlled in vitro laboratory studies

These applications are intended exclusively for scientific and laboratory investigation.  

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification designed to provide transparent and traceable batch-specific documentation. For this BPC-157 production batch, independent laboratory testing included:

• Assay content determination
• Purity assessment
• FTIR spectrum identification
• Retention time identification
• Molecular ion mass verification
• Bacterial endotoxin analysis
• Total aerobic microbial count
• Total yeast and mold count
• Elemental impurity screening
• Complete batch traceability

Independent laboratory analysis provides researchers with analytical information relating directly to the tested production batch rather than relying solely on general manufacturer specifications. This approach supports transparency, analytical traceability and consistency across Grail Formula research compounds.  

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently analysed research compounds supported by detailed Certificates of Analysis and transparent batch-specific laboratory documentation. For BPC-157 10 mg batch GF-BPC10-B242, independent analysis was performed by Liquilabs s.r.o. Czechia and the Certificate of Analysis was published on 15 August 2026. The analytical documentation includes assay determination, purity assessment, FTIR spectrum identification, retention time verification, molecular ion mass identification, bacterial endotoxin testing, microbiological analysis and comprehensive elemental impurity screening. This multi-method analytical approach provides researchers with extensive independent information regarding the identity and analytical characteristics of the tested research material.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.5 % purity confirmed by COA
• Assay content measured at 14.21 mg
• Identification evaluated by FTIR spectrum and retention time analysis
• Molecular ion mass identified at 1418 Da
• Bacterial endotoxin level of 0.086 EU/mg
• Total aerobic microbial count: 0 CFU/g
• Total yeast and mold count: 0 CFU/g
• Seven tested elemental impurities reported below 0.001 ppm
• Complete batch-specific COA traceability
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.